uniQure (QURE) Tax Provisions (2016 - 2026)
uniQure (QURE) posted quarterly Tax Provisions of $1.8 million for Q2 2026, up 333.18% year-over-year from $425000.0 in Q2 2025, and up 277.25% quarter-over-quarter from $488000.0 in Q1 2026.
uniQure (QURE) Tax Provisions (2016 - 2026) Analysis & Trends
uniQure's Tax Provisions history runs 10 years deep, the most recent figure standing at $1.8 million for Q2 2026.
- In Q2 2026, Tax Provisions rose 333.18% year-over-year to $1.8 million; the TTM figure through Jun 2026 stood at -$48.5 million (up 21.49% YoY), while the FY2025 annual figure was -$49.9 million, up 18.47% from the prior year.
- Tax Provisions for Q2 2026 stood at $1.8 million, up from $488000.0 in the prior quarter.
- The five-year high for Tax Provisions was $8.6 million in Q3 2025, with the low at -$78.0 million in Q4 2023.
- The 5-year median for Tax Provisions is $10000.0 (2023), against an average of -$12.3 million.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions sank 469.66% in 2022, then surged 9592.13% in 2025.
- uniQure's Tax Provisions stood at -$31.8 million in 2022, then sank by 145.0% to -$78.0 million in 2023, then gained by 19.53% to -$62.8 million in 2024, then gained by 5.3% to -$59.4 million in 2025, then soared by 103.1% to $1.8 million in 2026.
- Business Quant data shows QURE's Tax Provisions at $1.8 million in Q2 2026, $488000.0 in Q1 2026, and -$59.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | 1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.84 Mn |
| Mar 31, 2026 | 488,000.00 |
| Dec 31, 2025 | -59.43 Mn |
| Sep 30, 2025 | 8.63 Mn |
| Jun 30, 2025 | 425,000.00 |
| Mar 31, 2025 | 496,000.00 |
| Dec 31, 2024 | -62.75 Mn |
| Sep 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 948,000.00 |
| Mar 31, 2024 | 656,000.00 |
| Dec 31, 2023 | -77.98 Mn |
| Sep 30, 2023 | -69,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | -1.21 Mn |
| Dec 31, 2022 | -31.83 Mn |
| Sep 30, 2022 | -329,000.00 |
| Jun 30, 2022 | -318,000.00 |
| Mar 31, 2022 | -616,000.00 |
| Dec 31, 2021 | 79.64 Mn |
| Sep 30, 2021 | 89,000.00 |